Meiring, S.
Aydin, Ă–.
van Baar, A. C. G.
van der Vossen, E. W. J.
Rampanelli, E.
van Grieken, N. C. T.
Holleman, F.
Nieuwdorp, M.
Bergman, J. J. G. H. M.
Article History
Received: 8 February 2024
Accepted: 22 October 2024
First Online: 8 January 2025
Declarations
:
: SM, OA, AB, EV, NS, NvG, ER and MN have no conflict of interest. JB received research support from Fractyl laboratories Inc. for IRB-based studies and received a consultancy fee for a single advisory board meeting of Fractyl in September 2019. M.N. is in the scientific board of Caelus Pharmaceuticals, the Netherlands.